A commonly used epilepsy drug may be able to stop fatty liver disease and prevent Type 2 diabetes in obese people, according to a new study by Johns Hopkins researchers. Scientists found that valproic acid, an anticonvulsant and mood-stabilizing drug prescribed to epilepsy patients, reduced fat accumulation in the liver and lowered blood sugar levels […]
↧